Randox Food Diagnostics is planning roadshows within a major series targeting the honey market this year for antibiotic screening, as part of its efforts to increase face-to-face engagement with the market.
The UK-based company, which currently supplies the top three processors in Europe, has begun the first tranche of roadshows.
Randox Food Diagnostics, with its semi-automated analyser the RX Monza, recognized medium-to-large producers could benefit from the quicker turn-around and economies of scale offered by a fully-automated system.
Business development manager Aaron Tohill explained the rationale behind the move, "As the reputation of our patented multiplex drug residue screening system, BioChip Array Technology, continues to grow within the honey market, we've found the interest at Conferences and Exhibitions a revelation.
"Therefore we decided, rather than wait for events coming around, we would proactively create opportunities for the industry to experience BioChip Array for themselves."
Although not confined to these, initially the firm is targeting two strategic regions, as Tohill explained, "Building on the success of Apimondia in Ukraine we recognise the strength of the eastern European region, having been in Romania in January, with Poland planned for February, and Serbia in April.
"The other key region is Central America where we are planning a tour for Mexico in March, before arriving in Cuba in July."
"However we want to roll-out the demonstrations wherever demand arises so if producers in neighbouring countries or other regions are interested we are keen to hear from them," he added.
